Neovascular changes after pegaptanib in diabetics.
Bansal
A Gaurav
AG
Narayanan
R
R
Majji
A Babu
AB
Thomas
R
R
D052157:Aptamers, Nucleotide / Q000627:therapeutic use*; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D015861:Retinal Neovascularization / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
D052157:Aptamers, Nucleotide; D042461:Vascular Endothelial Growth Factor A; C495058:pegaptanib